Biomea Fusion reports blood sugar control with icovamenib in type 2 diabetes study

After FDA exit, Peter Marks pops up at Lilly

DRRA36 minutes ago 0

General Atlantic Singapore transfers 3.49 million Rubicon Research shares ahead of IPO

DRRA1 hour ago 0

Coverage of Sarepta Duchenne drug may be halted by N.Y. state Medicaid

DRRA1 hour ago 0

Bavarian Nordic Announces Topline P-II Trial Data of MVA-BN Mpox/Smallpox Vaccine in Younger Population

DRRA1 hour ago 0